China Resources Double-Crane Pharmaceutical (SHA:600062) obtained drug registration from China's medical products regulator for its compound glucose/electrolytes irrigation solution for craniocerebral surgery.
The solution is used in skull drilling, craniotomy and neuroendoscopic procedures, according to a Wednesday filing with the Shanghai bourse.